News of Note—Chickenpox outbreak, GeoVax and more

newspaper
In this week's news of note, GeoVax entered a new immunotherapy collaboration. (Pixabay)

Here is some other vaccine news of note for the week:

> A chickenpox outbreak in a North Carolina anti-vaccination hotbed is the state's worst in two decades. The Washington Post article

> GeoVax entered a collaboration with Leidos to test its vaccine candidates in conjunction with Leidos-developed checkpoint inhibitors. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> In a preclinical study, a DNA vaccine lowered the buildup of tau and beta-amyloid proteins associated with Alzheimer's disease. Release

Read more on

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.